Skip to Content

Givlaari Prices, Coupons and Patient Assistance Programs

Givlaari (givosiran) is a member of the miscellaneous metabolic agents drug class and is commonly used for Porphyria.

Givlaari Prices

The cost for Givlaari subcutaneous solution (189 mg/mL) is around $40,726 for a supply of 1 milliliter(s), depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Givlaari is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Givlaari availability.

This Givlaari price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution

189 mg/mL Givlaari subcutaneous solution
from $40,725.50 for 1 milliliter(s)
Quantity Per unit Price
1 milliliter(s) $40,725.50 $40,725.50

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.


Givlaari Coupons and Rebates

Givlaari offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Givlaari Copay Program: Eligible commercially insured patients may receive assistance with drug-related out-of-pocket expenses; for additional information contact the program at 833-256-2748.

Applies to:Givlaari
Number of uses:Per prescription until program expires

Patient Assistance Programs for Givlaari

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: HealthWell Foundation Copay Program

Elligibility requirements:
  1. May have insurance
  2. Varies
  3. FDA Approved Diagnosis - See Program Website for Details
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Givlaari (givosiran) Injection; Subcutaneous

Provider: Alnylam Assist (GIVLAARI)

Elligibility requirements:
  1. Must be uninsured or rendered uninsured
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must also be a US resident.
  5. This program also provides co-pay assistance for eligible patients. Contact the program for more details.

Applicable drugs:

  • Givlaari (givosiran) Injection; Subcutaneous